(1)
The Role of Intralesional Glucantime in Treating Cutaneous Leishmaniasis Lesions Complicated by Secondary Bacterial Infections: Research Article. Pak Euro. J. Med & LS 2025, 8 (1), 219-226. https://doi.org/10.31580/pjmls.v8i1.3238.